Authors Anne K Schlag, Jacob Aday, Iram Salam, Jo C Neill, David J Nutt Published February 3, 2022 Psychedelic medicines are a rapidly developing area of clinical research and public health policy. Despite an increasing body of studies highlighting their efficacy to treat a broad range of medical conditions, psychedelic drugs remain a controversial issue  …

Authors Annie Howard, Joanna C Neill, Anne Katrin Schlag, Charlotte Lennox Published October 25, 2021 Prior to the 1970s, psychedelics such as LSD were used and researched extensively. However, with the introduction of the UN convention Misuse of Drugs Regulations in 2001, all drugs were placed into one of five categories or ‘schedules’ based on  …

Summary Full Report Survey Data Does the UK support psilocybin research? Public perceptions of psilocybin-assisted therapy have been revealed in a new YouGov poll, commissioned by Drug Science. This is the first nationally representative poll of UK attitudes towards the medicalisation of psilocybin and support for policy changes (such as rescheduling psilocybin) to make this  …

Authors: Jacob S Aday, Emily K Bloesch, Christopher C Davoli Published: November 25, 2020 Public and scientific interest into psychedelic drugs has grown steadily over much of the last two decades, before an exponential increase in recent years. We contend that 2019, in particular, involved myriad notable changes in the science, industry, and deregulation of  …

Authors: JEC Anthony, A Winstock, JA Ferris, DJ Nutt Published: November 2, 2020 It is well documented that psychedelic drugs can have a profound effect on colour perception. After previous research involving psychedelic drug ingestion, several participants had written to the authors describing how symptoms of their colour blindness had improved. The Global Drugs Survey  …